Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown.
Jones
P M
PM
Turkstra
T P
TP
D000707:Anaphylaxis / Q000188:drug therapy*; D000732:Androstanols / Q000009:adverse effects*; D006801:Humans; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium